Diffuse Large B-cell Lymphoma of the Central Nervous System
📧 Sign up to get email alerts when something new happens for Diffuse Large B-cell Lymphoma of the Central Nervous System.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Relapsed or Refractory Primary Diffuse Large B-cell Lymphoma (DLBCL) of the Central Nervous System (CNS) [Phase 2]
Phase 2 clinical trial update for relapsed or refractory primary diffuse large B-cell lymphoma of the central nervous system; the study is c…
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: Testing the Addition of Lenalidomide and Nivolumab to the Usual Treatment for Primary CNS Lymphoma [Phase 1]
A Phase 1 trial evaluating the addition of lenalidomide and nivolumab to standard therapy for primary Diffuse Large B-Cell Lymphoma of the C…
-
CLINICAL_TRIALS trial_result · 2025-04-20Clinical Trial Update: Venetoclax, Ibrutinib, Prednisone, Obinutuzumab, and Revlimid (VIPOR) for Diffuse Large B-cell Lymphoma Involving the Central Nervous System [Phase 1]
Phase 1 clinical trial evaluating the VIPOR regimen (venetoclax, ibrutinib, prednisone, obinutuzumab, and lenalidomide) in central nervous s…
-
CLINICAL_TRIALS trial_result · 2024-10-16Clinical Trial Update: Nivolumab With or Without Varlilumab in Treating Patients With Relapsed or Refractory Aggressive B-cell Lymphomas [Phase 2]
Phase 2 trial evaluating nivolumab with or without varlilumab in relapsed or refractory aggressive B-cell lymphomas, including multiple DLBC…